NCT03787992 2025-04-11
Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer （FLAG）
Allist Pharmaceuticals, Inc.
Phase 3 Active not recruiting
Clinical Trials
1 trialsLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer × Gefitinib × Thoracic × Clear all